Archive for the ‘biotech/medical’ category: Page 1418
Oct 2, 2020
The robot smaller than the width of a hair
Posted by Muhammad Furqan in categories: biotech/medical, robotics/AI
This robot is smaller than the width of a hair đ€Ż And scientists hope it will be used to hunt down and destroy cancer cells.
Oct 1, 2020
This company is selling $500,000 flying vehicles that look like giant drones and can be flown without a pilotâs license
Posted by Quinn Sena in categories: biotech/medical, drones
Austin startup Lift Aircraft calls Hexa, its electric vertical takeoff and landing (eVTOL) aircraft the future of personal flight. So far, itâs been compared to a drone and a flying car.
Hexa is essentially a recreational vehicle for the air, able to fly in 15-minute intervals at low altitudes. Lift plans to market them to millennials with disposable income and anyone chasing adrenaline, because a pilotâs license isnât required. The COVID-19 pandemic delayed plans, but Lift still says it will be touring locations across the US where anyone meeting height, weight, and age requirements can pay to fly. As of November 2019, Lift says it had more than 15,000 flights on a waitlist to ride Hexa.
The company is also selling a small number of Hexas to buyers who will then rent them out. They cost $495,000, and only five are still available.
Oct 1, 2020
Drone completes longest organ delivery in Las Vegas
Posted by Quinn Sena in categories: biotech/medical, drones, health
Drone solution provider MissionGO has completed the longest organ delivery by drone in Las Vegas last week with the Nevada Donor Network. The two test flights were carrying a human organ and tissue to various locations around Las Vegas.
The first of the two flights was transporting research corneas from the Southern Hills Hospital and Medical Center to Dignity Health at the St. Rose Dominican, San MartĂn Campus. The flight demonstrated the viability, value, efficiency gains, and delivery speed of using drones to deliver organs and medical supplies.
The second flight delivered a research kidney from an airport to a location on the outskirts of a small town in the Las Vegas desert. This second flight was the one that marked the longest organ delivery by drone. The flight beat the previous record that was set in April 2019 also by MissionGO.
Oct 1, 2020
Potent neutralizing antibodies target new regions of coronavirus spike
Posted by Quinn Sena in category: biotech/medical
Researchers identified some of the most potent and diverse antibodies discovered to date that neutralize SARS-CoV-2, targeting multiple regions on the viral spike.
Oct 1, 2020
Crowdsourcing the Cure for Aging | Life Extension Research, Lifespan.IO, and You
Posted by Montie Adkins in categories: biotech/medical, education, life extension
LEAF president Keith Comito explains the story of Lifespan.io â a crowdsourcing platform and community to support biomedical research aimed at extending healthy human lifespan.
âŒâŒ More info and links below âŒâŒ
HOW CAN YOU SUPPORT US?
ââââââââââââââââââââââââââ
LEAF / Lifespan.io is a 501©(3) nonprofit organization. Everything weâve done thus far and everything we will do in the future is thanks to your support â please stand with us to fight the diseases of aging and increase healthy human lifespan.
Oct 1, 2020
Psychedelic Gold Rush? Compass Pathways Goes Public at More than $1B
Posted by Quinn Sena in categories: biotech/medical, government, law
Psilocybin startup Compass Pathways goes public at more than $1B. Hereâs why Wall Street is starting to see the value in psychedelics.
For several years, investors and psychonauts have predicted that psychedelic medicine would become the next billion-dollar industry, with some value estimates as high as $100 billion. They said substances like MDMA or psilocybin mushrooms would follow a similar regulatory path that cannabis took to the mainstream, going from a Schedule 1 narcotic to a legal, regulated, and highly lucrative medicine.
Continue reading “Psychedelic Gold Rush? Compass Pathways Goes Public at More than $1B” »
Oct 1, 2020
Transplants of stem-cell-grown neurons repair Parkinsonâs damage in mice
Posted by Quinn Sena in categories: biotech/medical, neuroscience
Stem cells are a promising experimental treatment for a variety of diseases. Now researchers at the University of Wisconsin-Madison have found that transplanting neurons grown from stem cells into the brains of mice with Parkinsonâs disease repaired the damaged brain circuits, improving the animalsâ motor skills.
In people afflicted with Parkinsonâs, neurons that produce dopamine begin to break down and die. The disease gradually presents as tremors, involuntary movements, and trouble with walking, speaking and other actions. While it currently canât be cured, studies are suggesting new ways to slow progression and reduce severity of symptoms through new drugs or repurposed old ones, deep brain stimulation or probiotic treatments.
But an emerging and potentially ground-breaking treatment involves stem cells. In several studies, researchers have used stem cells to grow new dopamine-producing neurons, and then transplant them into animals. And now the UW-Madison teamâs work has shown that doing so can help restore brain circuits damaged by Parkinsonâs.
This video explains the structural forms of DNA, why DNA have different forms and what are the differences present between each form.
Thank You For Watching.
Please Like And Subscribe to Our Channel: https://www.youtube.com/EasyPeasyLearning
Like Our Facebook Page: https://www.facebook.com/learningeasypeasy/
Join Our Facebook Group: https://www.facebook.com/groups/460057834950033
Sep 30, 2020
No bones about it: Wild gorillas donât develop osteoporosis like their human cousins
Posted by Kevin Huang in categories: biotech/medical, life extension
In a study of gorilla skeletons collected in the wild, Johns Hopkins Medicine researchers and their international collaborators report that aging female gorillas do not experience the accelerated bone loss associated with the bone-weakening condition called osteoporosis, as their human counterparts often do. The findings, they say, could offer clues as to how humans evolved with age-related diseases.
The study was published on Sept. 21, 2020, in Philosophical Translations of the Royal Society B.
âOsteoporosis in humans is a really interesting mechanical problem,â says Christopher Ruff, Ph.D., professor at the Center for Functional Anatomy and Evolution at the Johns Hopkins University School of Medicine. âIn terms of natural selection, there is no evolutionary advantage in developing bone loss with aging to the point of a potential fracture. By looking at close relatives of humans on the evolutionary tree, we can infer more about the origins of this condition.â